| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2296 | Pantoprazole sodium sesquihydrate | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2009-272 - Rev 04 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|23/08/2022 |
||
| 2219 | Lansoprazole | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2011-263 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 2531 | Clopidogrel hydrogen sulfate | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2011-267 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 2288 | Citalopram hydrobromide, DGR process | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2010-379 - Rev 03 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 2135 | Repaglinide | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2011-202 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 1564 | Sodium alendronate trihydrate | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2011-111 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 1028 | Metoprolol tartrate, Process-II | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2025-238 - Rev 01 | 2026/03/31 | Valid | 10/09/2030 | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; New application|CEP granted|10/09/2025 |
|
| 2576 | Voriconazole | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2013-286 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 2585 | Rizatriptan benzoate | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2012-273 - Rev 03 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 2191 | Atorvastatin calcium, Process II | SYNTHIMED LABS PRIVATE LIMITED Derabassi IN | 100052287;100092080 | CEP 2021-102 - Rev 04 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Renewal|CEP granted|31/03/2026; Notification|Accepted - CEP remains valid|14/08/2025; Major revision|CEP granted|26/08/2024; Minor revision|CEP granted|11/04/2023; Monograph revision|Accepted - CEP remains valid|19/07/2022; Notification|CEP granted|02/12/2021; New application|CEP granted|25/06/2021 |
||
| 429 | Progesterone, Micronised | I.P.S. INTERNATIONAL PHARMA SUPPLY LTD Majuro MH | 100048535;100080430 | CEP 2017-081 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Minor revision|CEP granted|29/05/2024; Renewal|CEP granted|30/11/2022; Minor revision|CEP granted|24/02/2022 |
||
| 2594 | Duloxetine hydrochloride | JUBILANT BIOSYS LIMITED Mysuru IN | 100055198;100098088 | CEP 2014-012 - Rev 02 | 2026/03/31 | Valid | Chemical | 2026/03/31 | Notification|CEP granted|31/03/2026; Notification|CEP granted|24/08/2022 |
||
| 1378 | Valproic acid | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2006-310 - Rev 05 | 2026/03/30 | Valid | Chemical | 2026/03/30 | Notification|CEP granted|30/03/2026 | ||
| 2232 | Losartan potassium, Process-II | ZHEJIANG JINGSHENG PHARMACEUTICAL CO., LTD. Taizhou CN | 100048181;100079705 | CEP 2021-288 - Rev 02 | 2026/03/30 | Valid | 10/02/2027 | Chemical | 2026/03/30 | Transfer of holdership|CEP granted|30/03/2026; Notification|CEP granted|25/03/2024; Minor revision|Accepted - CEP remains valid|23/05/2023; New application|CEP granted|10/02/2022 |
|
| 703 | Atenolol | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2004-030 - Rev 09 | 2026/03/30 | Valid | Chemical | 2026/03/30 | Notification|CEP granted|30/03/2026; Notification|CEP granted|06/03/2024; Minor revision|CEP granted|26/10/2023; Minor revision|Accepted - CEP remains valid|25/05/2022; Notification|CEP granted|25/11/2021; Notification|CEP granted|13/01/2021; Minor revision|CEP granted|01/10/2020 |
||
| 1028 | Metoprolol tartrate | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2000-056 - Rev 08 | 2026/03/30 | Valid | Chemical | 2026/03/30 | Notification|CEP granted|30/03/2026; Minor revision|Accepted - CEP remains valid|23/06/2025; Minor revision|CEP granted|26/06/2024 |
||
| 1286 | Alfacalcidol | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2000-100 - Rev 08 | 2026/03/30 | Valid | Chemical | 2026/03/30 | Minor revision|CEP granted|30/03/2026; Administrative procedure|CEP granted|17/01/2025; Notification|CEP granted|13/01/2025; Notification|Accepted - CEP remains valid|22/02/2024; Notification|Accepted - CEP remains valid|05/08/2022; Notification|CEP granted|20/12/2021; Minor revision|CEP granted|26/05/2021 |
||
| 1081 | Carboplatin | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2003-155 - Rev 05 | 2026/03/30 | Valid | Chemical | 2026/03/30 | Notification|CEP granted|30/03/2026; Major revision|CEP granted|26/03/2025; Minor revision|CEP granted|14/12/2023 |
||
| 2017 | Oxaliplatin, Process-II | SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN | 100008538;100018201 | CEP 2024-552 - Rev 01 | 2026/03/30 | Valid | 28/03/2030 | Chemical | 2026/03/30 | Notification|CEP granted|30/03/2026; New application|CEP granted|28/03/2025 |
|
| 330 | Gelatin, Alkaline hide gelatin; Bloom value: 160, 180, 200, 220, 240 and 250 g | CHENGDU CLASSIC GELATIN CO., LTD. Chengdu CN | 100054588;100096777 | CEP 2025-307 - Rev 00 | 2026/03/30 | Valid | 30/03/2031 | Chemical and TSE | 2026/03/30 | New application|CEP granted|30/03/2026 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号